Former Pilot Launched Stem Cell Donor Appeal
Los Angeles resident Chris Gordon is seeking a bone marrow donor to treat severe aplastic anaemia.
Updated on Sept. 23, 2026 in Philanthropy
Former RAF Chinook pilot Chris Gordon has launched a public appeal for a stem cell donor after being diagnosed with severe aplastic anaemia. The condition requires a transplant for survival, as his brother is only a partial match.
Why it matters
The case highlights the critical reliance of specialized medical treatments on international donor registries for patients lacking full family matches. For operators, it underscores the logistical and human impact of medical crises on workforce stability and family leave planning.
Chris Gordon currently requires blood transfusions twice per week to manage severe aplastic anaemia, a condition that prevents his bone marrow from generating new blood cells. The search is now focused on finding a full match to facilitate a transplant before the end of 2026.
The players
Chris Gordon
A former RAF Chinook pilot with 14 years of service who now resides in Los Angeles.
DKMS
A non-profit organization that manages an international registry for potential stem cell donors.
The details
Severe aplastic anaemia disrupts bone marrow function, necessitating regular blood transfusions and a successful stem cell transplant for long-term recovery. Potential donors must register through organizations like DKMS by completing a medical questionnaire and providing a cheek swab to test for genetic compatibility. This process is essential for patients like Gordon, who has a partial family match but requires a more precise donor to proceed with the necessary medical intervention.
Timeline
2013: Chris Gordon received the Distinguished Flying Cross.
September 2026: Chris Gordon launched his public donor appeal.
October 2026: Chris Gordon expects the birth of his baby son.
Late 2026: The window for Gordon to receive a successful transplant.
Market Landscape
The search for a stem cell donor follows the established protocols of the DKMS international donor network. This effort highlights the reliance on large-scale, global databases to address medical gaps where family-based options are insufficient.
Operators managing sudden long-term medical leave should prepare for the unpredictable operational impacts of employee health crises. Family leave policies and remote work flexibility remain critical tools for maintaining continuity when staff face life-altering medical challenges.
The takeaway
This case underscores the vital necessity of diverse donor registries in treating rare blood conditions. Employers should review their internal leave documentation to ensure support systems are ready for catastrophic medical events.
Further reading
For broader trends in medical support and charitable initiatives, explore the Philanthropy section.
More information
To learn more about the registry process, visit the DKMS stem cell donor registration portal.
